Home › Funds › Vestal Point Capital, LP › BMRN

Vestal Point Capital, LP position in BMRN

BIOMARIN PHARMACEUTICAL INC COM · Health Care

Vestal Point Capital, LP reported holding 6,025,000 shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM) in its Q2 2026 13F filing — a position valued at US$344.8M, representing 8.06% of its reported portfolio and ranking #1 among its reported holdings. Vestal Point Capital, LP has disclosed BMRN holdings in 8 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)6.03M sh
Reported value held$344.75M
Portfolio Weight8.06%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's BMRN position evolved

Vestal Point Capital, LP first disclosed a stake in BMRN in Q1 2024 at 175,000 shares (US$15.3M). The position peaked in Q2 2026 at 6,025,000 shares, worth US$344.8M. Across 8 filings, Vestal Point Capital, LP increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,025,000 shares valued at US$344.8M — an increase of 2,450,000 shares quarter over quarter.. Notable position changes include a 115% increase in Q4 2024 (shares rose 8% over the following quarter), a 261% increase in Q4 2025 (shares fell 5% over the following quarter), a 69% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 175.00K $15.28M New
Q3 2024 400.00K $28.12M New
Q4 2024 860.00K $56.53M Add
Q2 2025 500.00K $27.48M New
Q3 2025 830.00K $44.95M Add
Q4 2025 3.00M $178.29M Add
Q1 2026 3.58M $201.95M Add
Q2 2026 6.03M $344.75M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC COM) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Vestal Point Capital, LP held BMRN?

Vestal Point Capital, LP has disclosed BMRN holdings in 8 of the last 10 reported quarters, going back to Q1 2024.

What is Vestal Point Capital, LP's current position in BMRN?

As of Q2 2026, Vestal Point Capital, LP holds 6.03M shares of BMRN (BIOMARIN PHARMACEUTICAL INC COM), valued at $344.75M, representing 8.06% of its reported portfolio and ranking #1.

Has Vestal Point Capital, LP been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in BMRN. The position peaked in Q2 2026 at 6.03M shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.